| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038067 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic |
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |
| 02/17/2005 | US20050038050 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 02/17/2005 | US20050038041 Fungicide for agriculture, horticulture |
| 02/17/2005 | US20050038040 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders |
| 02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038033 use in treating respiratory system disorders such as asthma, incipient asthma and wheezy infant syndrome, chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, emphysema, chronic eosinophilic pneumonia, chronic obstructive pulmonary disease, allergies |
| 02/17/2005 | US20050038032 Quinoxaline compounds |
| 02/17/2005 | US20050038031 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 02/17/2005 | US20050038027 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038016 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050037925 Mixture with other herbicides |
| 02/17/2005 | DE10328533A1 New 6-amino-substituted indolinone derivatives, useful e.g. for treating tumours and angiogenesis, are inhibitors of receptor tyrosine kinases |
| 02/17/2005 | DE10326918A1 Substituierte Alkylamide Substituted alkyl amides |
| 02/17/2005 | CA2554566A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534975A1 Anthelmintic and insecticide pyrimidine derivatives |
| 02/17/2005 | CA2534905A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | CA2534811A1 Quinazoline derivatives as angiogenesis inhibitors |
| 02/17/2005 | CA2534528A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparationand use as modulators of apoptosis |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534494A1 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | CA2534422A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/17/2005 | CA2534240A1 Treatment for alzheimer's disease and related conditions |
| 02/17/2005 | CA2534101A1 2-`4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 02/17/2005 | CA2534096A1 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 02/17/2005 | CA2534057A1 Novel gamma-secretase inhibitors |
| 02/17/2005 | CA2533996A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | CA2533976A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533698A1 Lanthanide complexes preparation and uses thereof |
| 02/17/2005 | CA2533433A1 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
| 02/17/2005 | CA2533335A1 Substituted lactams and their use as anti-cancer agents |
| 02/17/2005 | CA2533182A1 Dry syrup containing loratadine |
| 02/17/2005 | CA2532910A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 02/17/2005 | CA2532452A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
| 02/16/2005 | EP1506966A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystaline structures thereof |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506960A1 Indole compounds as inhibitors of tubulin polymerisation for the treatment of angiogenesis-related disorders |
| 02/16/2005 | EP1506779A1 (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina |
| 02/16/2005 | EP1506189A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof |
| 02/16/2005 | EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/16/2005 | EP1506187A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506185A1 Novel compounds and their use |
| 02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/16/2005 | EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506040A2 Selective inos inhibitors for the treatment of respiratory diseases and conditions |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1505945A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | CN1582286A Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 02/16/2005 | CN1582284A Aminopyrimidines and pyridines |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582279A Peroxisome proliferator activated receptor agonists |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582166A Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 02/16/2005 | CN1580179A White electroluminescent polymer material and its preparing method |
| 02/16/2005 | CN1580056A Heterocyclic derivatives their preparing methods and uses |
| 02/16/2005 | CN1580055A Quinolone carboxylic acid derivatives and their salts |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/16/2005 | CN1189465C Vitamin D3 analogs with bis C-20 side chains |
| 02/16/2005 | CN1189461C Method of producing imidacloprid |
| 02/15/2005 | US6855823 Selective iGluR5 receptor antagonists |
| 02/15/2005 | US6855730 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
| 02/15/2005 | US6855725 Excitatory amino acid receptor antagonists |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855717 A 2(2-(4-benzamido-cyclohexyl)ethyl)-1,2,3,4-tetrahydroisoquinol ine derivatives, for use in psychotherapy |
| 02/15/2005 | US6855716 Dihydropyrimidine compounds and compositions containing the same |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855714 For therapy of inflammatory, allergic, infectious or autoimmune diseases |
| 02/15/2005 | US6855713 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
| 02/15/2005 | US6855710 Antiproliferative agents; antitumor agents |
| 02/15/2005 | US6855709 Psychological disorders; central nervous system disorders |
| 02/15/2005 | US6855708 N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| 02/15/2005 | CA2251927C Cycloalkylaminomethylpyrrolidine derivatives |
| 02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012290A1 Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors |
| 02/10/2005 | WO2005012289A1 Novel salt of (r) - pantoprazole |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012286A1 Substituted pyridones and pyrimidinones with antiinflammatory properties |
| 02/10/2005 | WO2005012285A1 An improved process for the preparation of moxifloxacin hydrochloride |